|
|
||||||||
Clinical Chemistry, Vol 38, 1981-1987, Copyright © 1992 by American Association for Clinical Chemistry
H Alfthan, C Haglund, J Dabek and UH Stenman
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Finland.
Sensitive, specific time-resolved immunofluorometric assays were used to measure the concentrations of human choriogonadotropin (hCG), free beta-subunit (beta-hCG), and the core fragment of beta-hCG (c beta-hCG) in serum and urine of men and nonpregnant women without evidence of cancer. Concentrations of hCG and beta-hCG were measurable in 59-70% of serum samples and in 50-59% of urine samples. c beta-hCG was mostly undetectable in serum but measurable in 81% of urine samples. Concentrations were higher in women than in men, and hCG concentrations increased with age. Therefore, reference ranges based on the 97.5 percentile were calculated separately for women and men and for those < 50 and > 50 years. However, concentrations of hCG correlated much more strongly with those of follicle-stimulating hormone than with age. hCG concentrations in serum were similar to those reported before, but beta- hCG concentrations were below the detection limit of earlier assays, and the upper reference limit was one-fifth to one-tenth the cutoff concentrations used earlier. In urine, hCG and c beta-hCG were the major forms of hCG, and their concentrations were similar to those of hCG in serum.
The following articles in journals at HighWire Press have cited this article:
![]() |
U.-H. Stenman Commentary Clin. Chem., January 1, 2008; 54(1): 213 - 214. [Full Text] [PDF] |
||||
![]() |
A. Lempiainen, K. Hotakainen, C. Blomqvist, H. Alfthan, and U.-H. Stenman Increased Human Chorionic Gonadotropin Due to Hypogonadism after Treatment of a Testicular Seminoma Clin. Chem., August 1, 2007; 53(8): 1560 - 1561. [Full Text] [PDF] |
||||
![]() |
M. Rajecki, A. Kanerva, U.-H. Stenman, M. Tenhunen, L. Kangasniemi, M. Sarkioja, M. Y. Ala-Opas, H. Alfthan, A. Sankila, E. Rintala, et al. Treatment of prostate cancer with Ad5/3{Delta}24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivo Mol. Cancer Ther., February 1, 2007; 6(2): 742 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Valmu, H. Alfthan, K. Hotakainen, S. Birken, and U.-H. Stenman Site-specific glycan analysis of human chorionic gonadotropin {beta}-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry Glycobiology, December 1, 2006; 16(12): 1207 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu The classification, functions and clinical use of different isoforms of HCG Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E van Trommel, F. C G J Sweep, C. P T Schijf, L. F A G Massuger, and C. M G Thomas Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios Eur. J. Endocrinol., October 1, 2005; 153(4): 565 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Cole "Background" Human Chorionic Gonadotropin in Healthy, Nonpregnant Women Clin. Chem., October 1, 2005; 51(10): 1765 - 1766. [Full Text] [PDF] |
||||
![]() |
J. A. Snyder, S. Haymond, C. A. Parvin, A. M. Gronowski, and D. G. Grenache Diagnostic Considerations in the Measurement of Human Chorionic Gonadotropin in Aging Women Clin. Chem., October 1, 2005; 51(10): 1830 - 1835. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.-H. Stenman Standardization of Assays for Human Chorionic Gonadotropin Clin. Chem., May 1, 2004; 50(5): 798 - 800. [Full Text] [PDF] |
||||
![]() |
R. K. Iles, M. K. Javid, L. K. Gunn, and T. Chard Cross-Reaction with Luteinizing Hormone ß-Core Is Responsible for the Age-dependent Increase of Immunoreactive ß-Core Fragment of Human Chorionic Gonadotropin in Women with Nonmalignant Conditions Clin. Chem., April 1, 1999; 45(4): 532 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Korhonen, H. Alfthan, P. Ylostalo, J. Veldhuis, and U.-H. Stenman Disappearance of human chorionic gonadotropin and its {alpha}- and ß-subunits after term pregnancy Clin. Chem., November 1, 1997; 43(11): 2155 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.-H. Stenman, L. Unkila-Kallio, J. Korhonen, and H. Alfthan Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control Clin. Chem., July 1, 1997; 43(7): 1293 - 1298. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |